欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/1840/001
药品名称
Lambrinex
活性成分
Atorvastatin calcium salt 10.0 mg
剂型
Film-coated tablet
上市许可持有人
Pharmathen S.A. Dervenakion 6 153 51 Pallini Greece
参考成员国 - 产品名称
Denmark (DK)
Lambrinex
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Greece (GR)
Cyprus (CY)
LAMBRINEX 10mg FC TABS
许可日期
2011/01/19
最近更新日期
2025/01/22
药物ATC编码
C10AA05 atorvastatin
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
PIL_CC_Atorvastatin_1840_IA_027_cl
Date of last change:2025/01/22
Final SPC
|
SPC_CC_Atorvastatin 1840_IA_027_cl
Date of last change:2025/01/22
Final Product Information
|
1840_common_pl_clean
Date of last change:2024/09/06
Final Labelling
|
common_outer_clean_ib016
Date of last change:2024/09/06
Final Labelling
|
common_pl_clean_ib016
Date of last change:2024/09/06
Final Labelling
|
common_spc_clean_ib016
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase